Skip to content

The medicines and regimens used to treat drug-resistant tuberculosis (DR-TB) have evolved several times in the last few years. Here we present a collection of TAG materials developed to support community advocates with the information and resources they need to promote treatment literacy and push for universal access to the best available treatment regimens and standards of care.

This suite of materials is designed to build community treatment literacy on the side effects of medications used to treat DR-TB and to support community engagement in active drug safety monitoring and management (ADSM) initiatives.

The Resource Book empowers people undergoing treatment for drug-resistant TB to know the medications they are taking and to be active participants in their own care.

The Activity Book includes strategies and tools to help people better describe and track their symptoms and communicate them to healthcare providers. It also includes activities to help people on DR-TB treatment feel more centered and connected to their bodies.

Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis published in 2025 lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB. The Activist Guide reviews the evidence-base behind these regimens, important considerations for key populations affected by TB, the access landscape, and more. Also available in: Bahasa Indonesia, Hausa, Portuguese, Russian

Educational materials to support community-based and civil society organizations leading treatment literacy, peer support, and community-led monitoring activities:

“Options for Treating Drug-Resistant Tuberculosis: Which Regimen is Right for Me?”

compares key attributes, risks and benefits, and considerations related to the preferences and needs of the person undergoing treatment that should be discussed when determining which regimen to use.

Read the report



Translated languages available:
Bahasa Indonesia, Portuguese (coming soon), Russian

“Side Effects and Clinical and Laboratory-Based Monitoring of Treatment for Drug-Resistant Tuberculosis: What to Expect”

walks through lab tests and clinical exams that people should expect to receive prior to treatment initiation, at regular intervals during treatment, and in response to specific problems or concerns.

Read the report


Translated languages available:
Amharic, Bahasa Indonesia, Hausa, Portuguese (coming soon), Russian, Zulu

“Talking with People About Your Diagnosis of Drug-Resistant Tuberculosis”

is written to help people recently diagnosed with drug-resistant TB think about how to approach disclosing and discussing their diagnosis with family and other close contacts.

 

 

Read the report


Translated languages available:
Amharic, Bahasa Indonesia, Portuguese (coming soon), Zulu

Back To Top